HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LBH589

a hydroxamic acid analog histone deacetylase inhibitor from Novartis
Also Known As:
LBH 589; NVP-LBH589; panobinostat
Networked: 248 relevant articles (41 outcomes, 93 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Atadja, Peter: 36 articles (01/2015 - 02/2005)
2. Fiskus, Warren: 13 articles (05/2014 - 02/2005)
3. Richardson, Paul G: 10 articles (01/2016 - 11/2011)
4. Ocker, Matthias: 9 articles (01/2016 - 01/2010)
5. Bhalla, Kapil N: 9 articles (05/2014 - 04/2009)
6. Johnstone, Ricky W: 8 articles (11/2015 - 07/2008)
7. Prince, H Miles: 8 articles (05/2014 - 07/2008)
8. Rao, Rekha: 8 articles (04/2012 - 12/2006)
9. San-Miguel, Jesús F: 7 articles (01/2016 - 05/2010)
10. Sharma, Sunil: 7 articles (01/2015 - 08/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Multiple Myeloma
3. Prostatic Neoplasms (Prostate Cancer)
4. Glioblastoma (Glioblastoma Multiforme)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. LBH589
3. bortezomib (Velcade)
4. vorinostat (suberoylanilide hydroxamic acid)
5. gemcitabine
6. everolimus
7. Histone Deacetylases (Histone Deacetylase)
8. sorafenib (BAY 43-9006)
9. Dexamethasone (Maxidex)
10. PXD101

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Castration
4. Radiotherapy
5. Stem Cell Transplantation